loader
Please Wait
Applying Filters...
menu
    • menu

    Digital Content for DESIPRAMINE HCL

    Client Email Product
    Polpharma is a Polish CDMO of APIs and a significant European API producer, delivering products to companies worldwide.

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-09-09

    Virtual Booth

    Contact Supplier

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-09-09

    Virtual Booth

    Contact Supplier

    Menu

    DESIPRAMINE HCL

    ACTIVE PHARMA INGREDIENTS

    PRICE INFORMATION

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 492Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Alembic Pharms`s Generic Desipramine HCL Receives Approval In US
    Alembic Pharms`s Generic Desipramine HCL Receives Approval In US

    12 Jul 2021

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209785

    FDA
    12 Jul 2021
    Share Share
    FTC imposes conditions on Amneal acquisition of Impax
    FTC imposes conditions on Amneal acquisition of Impax

    11 Jul 2018

    // PHARMA LETTER

    https://www.thepharmaletter.com/in-brief/brief-ftc-imposes-conditions-on-amneal-acquisition-of-impax

    PHARMA LETTER
    11 Jul 2018
    Share Share
    ANI Pharmaceuticals Completes Acq.of Generic Products & Assets from Amneal/Impax
    ANI Pharmaceuticals Completes Acq.of Generic Products & Assets from Amneal/Impax

    07 May 2018

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/ani-pharmaceuticals-completes-acquisition-of-generic-products-and-assets-from-amnealimpax-300642867.html

    PR NEWSWIRE
    07 May 2018
    Share Share
    Ingenus Pharms Generic Desipramine Hydrochloride Receives Approval In US
    Ingenus Pharms Generic Desipramine Hydrochloride Receives Approval In US

    29 Dec 2017

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204963

    FDA
    29 Dec 2017
    Share Share
    Indicus's Generic Desipramine HCl approved in US as antidepressant drug
    Indicus's Generic Desipramine HCl approved in US as antidepressant drug

    05 May 2016

    // FDA

    https://www.pharmacompass.com/pdf/news/indicuss-generic-desipramine-hcl-approved-in-us-as-antidepressant-drug-1462882780.pdf

    FDA
    05 May 2016
    Share Share
    Amneal Pharm's Generic Desipramine Hydrochloride approved in US for treatment of depression
    Amneal Pharm's Generic Desipramine Hydrochloride approved in US for treatment of depression

    17 Mar 2016

    // FDA

    https://www.pharmacompass.com/pdf/news/amneal-pharms-generic-desipramine-hydrochloride-approved-in-us-for-treatment-of-depression-1458722573.pdf

    FDA
    17 Mar 2016
    Share Share